Eversana Intouch

FEBRUARY 23, 2023

Let’s talk about the current economic uncertainty and what it means for pharma marketers. Biopharma valuations are down, especially for public and earlier-stage companies. Talent shortages continue, particularly in executive and specialized R&D roles, while simultaneously layoffs , especially in biotech, are on the rise.

Marketing 52

Marketing Pharma Patients Insurance 52

PM360

OCTOBER 3, 2023

PRODUCT LAUNCH OF THE YEAR NEXTSTELLIS (Mayne Pharma and EVERSANA INTOUCH) RELAUNCH/REVITALIZATION OF THE YEAR VRAYLAR (AbbVie Inc. Director, Obesity Market Access Strategy, Novo Nordisk Medical Device/Diagnostics: Brett Sarnoff, Vice President of Marketing Medical Device & Pharma Systems, North America, B. Braun Medical, Inc.

Education 122

Education Marketing Media Management 122

PM360

AUGUST 24, 2023

Each of their trailblazing efforts result in much more than personal or organization success, it results in better quality of life for patients, better care options for healthcare providers, and happier and healthier people around the world.” Weiss has also made substantial efforts to give back to the community at large.

Marketing 52

Marketing Education Media Healthcare 52

European Pharmaceutical Review

FEBRUARY 21, 2023

Crucially, January 2023 marked a key moment: the Medicines and Healthcare products Regulatory Agency (MHRA) granted Celadon Pharmaceuticals the first good manufacturing practice (GMP) registration since legalisation in 2018 for high Δ9-tetrahydrocannabinol (THC) cannabis active pharmaceutical ingredient (API).

Medicine 129

Medicine Manufacturing Specialization Pharmaceutical 129

Clarivate

NOVEMBER 17, 2021

In this episode of Conversations in Healthcare , Carolyn Hynes from AstraZeneca discusses the importance of regulatory intelligence. Carolyn Hynes: I think of regulatory intelligence (RI) as a very specialized role within the regulatory affairs function. Subscribe to Conversations in Healthcare .

Pharma 52

Pharma Healthcare Healthcare Specialization 52

PM360

OCTOBER 5, 2023

Now, Real Chemistry is at the forefront of applying analytics, data, and artificial intelligence to the biopharma and healthcare industry and, in 2022, the company achieved its 21st consecutive year of double-digit growth. Weiss has also made substantial efforts to give back to the community at large.

Education 52

Education Marketing Media Biopharma 52

PM360

SEPTEMBER 15, 2022

But battling information asymmetry is one of the best ways to address the ongoing inequities in our healthcare system. But to shift the industry’s approach to healthcare, all stakeholders must move the efforts, attention, and education necessary to find a common ground and ensure that the patients’ interests are always driving development.

Patients 98

Patients Healthcare Healthcare Marketing 98

Clarivate

MAY 24, 2022

The consortium aims to promote awareness for rare diseases within the healthcare community and general public, address the impending issue of drug availability and improve the quality of life of rare disease patients. Multinational pharmas seek entry for their products. Source: Mainland China’s Center for Drug Evaluation. References.

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

PM360

JUNE 11, 2022

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. Patients want to know other patients are involved in what pharma is doing. Learn how pharma is involving them. They want to hear about those patients’ experiences.

Patients 59

Patients Pharma Education Media 59

European Pharmaceutical Review

OCTOBER 2, 2023

CPHI Barcelona, the renowned global pharma event, is set to take centre stage from 24 to 26 October 2023 at Fira Barcelona Gran Via, Spain. CPHI creates connections and inspires partnerships across the global pharma community. CPHI creates connections and inspires partnerships across the global pharma community.

Manufacturing 98

Manufacturing Pharma Engineering Networking 98

PM360

JUNE 30, 2022

Inizio Advisory: This unit helps pharma, biotech, and life sciences companies to develop, execute, and operationalize their strategies across portfolio licensing and development, new product launches, established product and franchise strategy, HEOR, pricing, and market access.

Specialization 97

Specialization Consulting Healthcare Healthcare 97

PM360

NOVEMBER 21, 2022

Those in the biopharma industry can play a pivotal role in shortening the journey to diagnosis if they learn from patients what critical pieces had to fall into place before they were diagnosed. It’s also in these communities where biopharma finds the best opportunities to connect with their stakeholders.

Patients 52

Patients Medicine Biopharma Media 52

Clarivate

MAY 24, 2023

In recent years, FDA has increasingly shown an openness to surrogate endpoints as the basis for approval of a therapy,” said Bethany Kiernan, Director of Healthcare Research Analytics for Infectious, Niche and Rare Diseases at Clarivate.

Patients 52

Patients Food and Drug Administration Biopharma FDA 52

Pharmaceutical Technology

APRIL 24, 2023

Because biologics work with live cells, manufacturing them is difficult, and highly specialized facilities and infrastructure are needed. Free Whitepaper Choosing the ‘right’ CRO/CDMO in Biopharma: What has changed? Biopharma outsourcing has rapidly developed.

Manufacturing 52

Manufacturing Food and Drug Administration Biopharma Sales 52

Pharmaceutical Technology

JANUARY 25, 2023

Although expert opinions differ on the future of special purpose acquisition companies (SPACs), some companies are continuing to explore their use. In December 2022, AEON Biopharma, a biopharmaceutical company, announced its plans to go public through a merger with the SPAC Priveterra Acquisition Corp. trillion of dealmaking firepower.

Marketing 69

Marketing Biopharma Pharma Competition 69